Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-063927

Chief Executive Officer sold 6,000 shares at an average $61.55 ($369,288)

  • Chief Executive Officer acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schenkein David P Chief Executive Officer 2017-12-01 Option exercise +6,000 $0.30 $1,815 6,000 D: show line 1 in the form
Schenkein David P Chief Executive Officer 2017-12-01 Sale −5,600 $61.51 $344,456 400 D: show line 2 in the form
Schenkein David P Chief Executive Officer 2017-12-01 Sale −400 $62.08 $24,832 0 D: show line 3 in the form
Open-market sales · 6,000 sh · avg $61.55 · $369,288

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Schenkein David P Chief Executive Officer 2017-12-01 Option exercise · Stock option (right to buy) −6,000 20,656 D: show line 4 in the form
Loading xslF345X03/doc4.xml…